Physician profile
Danielle Ucci
NPI 1811308505
$23,557.77
in general payments reported to CMS, 2019-2025
49 companies · $250 in 2025
The $250 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $5,855 · 2023: $2,598 · 2024: $153 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,940 · Education: $61.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,939.82 |
| Education | $61.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $12,414.42 | 2021-2025 | |
| Allergan, INC. | $2,675.00 | 2021 | |
| Nevro Corp. | $791.94 | 2022-2023 | Senza |
| Lilly USA, LLC | $602.73 | 2021-2023 | Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $466.13 | 2021-2023 | Trintellix |
| Amgen INC. | $454.64 | 2021-2025 | Tepezza, Otezla, Repatha |
| Otsuka America Pharmaceutical, INC. | $411.39 | 2021-2023 | Rexulti, Abilify Maintena |
| Novo Nordisk INC | $373.58 | 2021-2023 | Rybelsus, Ozempic, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $338.76 | 2021-2023 | |
| Pfizer INC. | $317.28 | 2021-2023 | |
| Biohaven Pharmaceuticals, INC. | $304.24 | 2021 | |
| Janssen Pharmaceuticals, INC | $294.41 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $257.46 | 2021-2023 | Belsomra, Verquvo, Januvia |
| Kowa Pharmaceuticals America, INC. | $256.12 | 2021-2023 | Livalo, Seglentis |
| Corium, LLC | $253.81 | 2022-2023 | Azstarys |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Ucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.